Who Has Been Buying Radius Health, Inc. (NASDAQ:RDUS) Shares?

We’ve lost count of how many times insiders have accumulated shares in a company that goes on to improve markedly. The flip side of that is that there are more than a few examples of insiders dumping stock prior to a period of weak performance. So before you buy or sell Radius Health, Inc. (NASDAQ:RDUS), you may well want to know whether insiders have been buying or selling.

What Is Insider Selling?

It is perfectly legal for company insiders, including board members, to buy and sell stock in a company. However, most countries require that the company discloses such transactions to the market.

We don’t think shareholders should simply follow insider transactions. But it is perfectly logical to keep tabs on what insiders are doing. As Peter Lynch said, ‘insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.’

Check out our latest analysis for Radius Health

The Last 12 Months Of Insider Transactions At Radius Health

Over the last year, we can see that the biggest insider purchase was by insider Jessica Hopfield for US$246k worth of shares, at about US$19.23 per share. So it’s clear an insider wanted to buy, at around the current price, which is US$20.32. That means they have been optimistic about the company in the past, though they may have changed their mind. While we always like to see insider buying, it’s less meaningful if the purchases were made at much lower prices, as the opportunity they saw may have passed. The good news for Radius Health share holders is that insiders were buying at near the current price.

Over the last year, we can see that insiders have bought 20300 shares worth US$391k. In the last twelve months Radius Health insiders were buying shares, but not selling. The chart below shows insider transactions (by individuals) over the last year. By clicking on the graph below, you can see the precise details of each insider transaction!

NasdaqGM:RDUS Recent Insider Trading, August 5th 2019
NasdaqGM:RDUS Recent Insider Trading, August 5th 2019

Radius Health Insiders Bought Stock Recently

It’s good to see that Radius Health insiders have made notable investments in the company’s shares. Specifically, Senior Vice President of Sales & Marketing Joseph Kelly bought US$97k worth of shares in that time, and we didn’t record any sales whatsoever. This is a positive in our book as it implies some confidence.

Insider Ownership of Radius Health

Looking at the total insider shareholdings in a company can help to inform your view of whether they are well aligned with common shareholders. We usually like to see fairly high levels of insider ownership. From looking at our data, insiders own US$3.6m worth of Radius Health stock, about 0.4% of the company. We prefer to see high levels of insider ownership.

So What Do The Radius Health Insider Transactions Indicate?

It is good to see the recent insider purchase. And an analysis of the transactions over the last year also gives us confidence. But we don’t feel the same about the fact the company is making losses. While the overall levels of insider ownership are below what we’d like to see, the history of transactions imply that Radius Health insiders are reasonably well aligned, and optimistic for the future. If you are like me, you may want to think about whether this company will grow or shrink. Luckily, you can check this free report showing analyst forecasts for its future.

If you would prefer to check out another company — one with potentially superior financials — then do not miss this free list of interesting companies, that have HIGH return on equity and low debt.

For the purposes of this article, insiders are those individuals who report their transactions to the relevant regulatory body. We currently account for open market transactions and private dispositions, but not derivative transactions.

We aim to bring you long-term focused research analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material.

If you spot an error that warrants correction, please contact the editor at editorial-team@simplywallst.com. This article by Simply Wall St is general in nature. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Simply Wall St has no position in the stocks mentioned. Thank you for reading.